Founded in 2017
InterVenn Biosciences combines AI/ML, glycoproteomics & LC/MS for biomarker and target discovery in Oncology and other disease indications.
Sunil Dhaliwal
Investor
Aldo Carrascoso
CEO and Co-Founder
FounderBrian Hogan
Chief Financial Officer
Jia Ying Chai
Laboratory Technician
Paul Aiyetan
Senior Scientist
Axel Kornerup
Country Manager
Michael Angelo Tablante
Software QA Engineer
Xin Cong
VP, Pre-clinical R&D
Jeremy Franzen
Vice President Technology Operations